![H. Perez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
H. Perez
Director/Miembro de la Junta en
Presidio Pharmaceuticals, Inc.
.
Perfil
H.
Daniel Perez is the founder of Naia Rare Diseases LLC, which was founded in 2014.
He held the title of Chairman & Chief Executive Officer at Naia Rare Diseases LLC.
Currently, Dr. Perez is the Director at Presidio Pharmaceuticals, Inc. and the Professor at The University of California, San Francisco.
In the past, he was the President & Chief Executive Officer at Berlex Biosciences from 1993 to 2006.
He also served as the Chairman at Accelerated Pharma, Inc. from 2015 to 2016, Independent Director at Cleveland BioLabs, Inc. from 2006 to 2011, Director at Celtaxsys, Inc. from 2011 to 2013, Director at Hyperion Therapeutics, Inc., and Venture Partner at Bay City Capital LLC.
Dr. Perez obtained a doctorate degree from Universidad de Buenos Aires and an undergraduate degree from Universidad Mariano Egaña.
Cargos activos de H. Perez
| Empresas | Cargo | Inicio |
|---|---|---|
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops small-molecule antiviral therapeutics | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de H. Perez.
| Empresas | Cargo | Fin |
|---|---|---|
| ACCELERATED PHARMA INC | Presidente | 01/02/2016 |
| STATERA BIOPHARMA, INC. | Director/Miembro de la Junta | - |
Berlex Biosciences | Director Ejecutivo | 01/01/2006 |
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Director Ejecutivo | - |
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases | Presidente | - |
Formación de H. Perez.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
84
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs | Health Technology |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Develops foundational therapies to treat inflammation in rare and orphan designated diseases | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Accelerated Pharma, Inc.
 Accelerated Pharma, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops treatment for cancer | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Mariano Egaña
 Universidad Mariano Egaña Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops small-molecule antiviral therapeutics | Health Technology |
Berlex Biosciences | |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Health Services |
- Bolsa de valores
- Insiders
- H. Perez
Elige MarketScreener 
